Dublin, March 25, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/vl4t7b/bioabsorbable) has announced the addition of the "Bioabsorbable Stents - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Bioabsorbable Stents in Thousand Units and in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 15 companies including many key and niche players such as:
- Abbott Laboratories (US)
- Amaranth Medical, Inc. (US)
- Arterial Remodeling Technologies SA (France)
- BIOTRONIK SE & Co. KG (Germany)
- Elixir Medical Corp. (US)
- Kyoto Medical Planning Co., Ltd. (Japan)
- REVA Medical, Inc. (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
- Bioabsorbable Stents - Transforming the Interventional Cardiology Market
- Evolution of Coronory Stents
- Global Coronory Stents Market - A Few Key Facts
- Bioabsorbable Stents Poised to Replace Drug-Eluting Stents in Future
- How are Bioabsorbable Stents Better than Drug-Eluting and Bare Metal Stents
- Clinical Trial Results Corroborate BVS Therapy
- Absorb® - The First Commercially Available Bioabsorbable Stent
- Competition - Abbott Leads the Race
- Bioabsorbable Stents in Pipeline: 2013
- Europe - The Largest Market for Biabsorbable Stents
- Developing Countries - Hot Spots for Growth
- Market Challenges and Threats
- Technological Challenges
- Safety- Efficacy Factor
- Regulatory Challenges
- Price Factor
- Alternative Therapies/Devices: Threats to Coronary Stents
- Cell Transplantation - A Threat to Coronary Stents
2. MARKET TRENDS, DRIVERS & CHALLENGES
- Global Menace of Coronary Artery Disease - A Major Growth Driver
- Restenosis Creates the Need for Bioabsorbable Stents
- Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
- Rising Middle Class Population Aids Growth
- Rising Healthcare Expenditure: Opportunities in Store
- Risk of CAD in Obesity Offers Prospects for Coronary Stenting
- Diabetics at Higher Risk of Heart Diseases
- The Hypertension-Cholesterol Link to Drive Demand
- Spurt in Medical Tourism Offers Growth Opportunities
3. PIPELINE ANALYSIS
- ART Bioabsorbable Stent (Arterial Remodeling Technologies, France)
- DREAMS (BIOTRONIK, Germany)
- DESolve Coronary Scaffold (Elixir Medical, US)
- IGAKI-TAMAI® (Kyoto Medical Planning, Japan)
- ReZolve® (REVA Medical Inc., US)
- IDEAL (Bioabsorbable Therapeutics, US)
- Magnesium-Based Stent (Luxfer, UK)
- LifeTech Iron (LifeTech, China)
- The Xinsorb BRS (Huaan Biotechnology Group, China)
4. REGULATORY FRAMEWORK
5. PRODUCT OVERVIEW
- Coronary Artery Disease (CAD) - A Perspective
- Causes and Symptoms
- Treatment Options for Coronary Artery Disease
- Percutaneous Coronary Intervention (PCI)
- Coronary Stenting
- Types of Coronary Stents
- Bare Metal Stents (BMS)
- Drug Eluting Stents (DES)
- Bioabsorbable Stents
- Design and Composition of Bioabsorbable Stents
- Different Types of Bioabsorbable Stents
- Metallic Bioabsorbable Stents
- Polymer Bioabsorbable Stents
- Degradation Period of Select Bioabsorbable Materials
6. RECENT INDUSTRY ACTIVITY
- Elixir Receives CE Approval for Bioresorbable Stent
- Arterial Remodeling Signs Collaboration Agreement with Terumo
- Abbott Concludes Enrollment for Absorb Clinical Trials for US, China, and Japan
- Abbott Initiates Clinical Trials of ABSORB IV BVS
- Abbott Initiates Japanese Clinical Trial of Absorb BVS
- Abbott Initiates ABSORB III Clinical Trial in the US
- ART Conducts First-in-Human Clinical Trial of ART Bioabsorbable Stent
- Kyoto Medical Releases Long-Term Safety and Efficacy Data for its IGAKI-TAMAI® Stent
- Abbott Laboratories Launches Absorb BVS in Europe and Other Markets
7. FOCUS ON SELECT GLOBAL PLAYERS
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 15 (including Divisions/Subsidiaries - 16)
- The United States (9)
- Japan (1)
- Europe (3)
- - France (1)
- - Germany (1)
- - The United Kingdom (1)
- - Asia-Pacific (Excluding Japan) (3)
For more information visit http://www.researchandmarkets.com/research/vl4t7b/bioabsorbable